Category: Direct-to-Consumer

6 Online Options for Insomnia Therapy

There aren’t enough practitioners of cognitive behavioral therapy for insomnia (CBT-I) to allow for all sufferers in need of the gold-standard treatment to get in-person help, but online programs can fill some patients’ needs. We profile online CBT-I options, including the peer-reviewed research that supports their programs, their effectiveness data, and price points.

Read More

Rozerem Launches Direct-to-Consumer Campaign

Physicians who treat insomnia may soon find their patients asking for a new medication. After a year of marketing the insomnia medication Rozerem to physicians, the drug maker Takeda Pharmaceuticals North America, Lincolnshire, Ill, is taking its message direct to consumers with an advertising campaign launching today.

Read More